Hugh S Taylor MD
Reproductive Endocrinology & Infertility
Anita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine
Join to View Full Profile
200 West Campus Drive2ND floorOrange, CT 06477
Phone+1 203-785-4708
Dr. Taylor is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hugh Taylor is an obstetrician/gynecologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from University of Connecticut School of Medicine and has been in practice 29 years. He specializes in reproductive endocrinology & infertility and is experienced in endometriosis, infertility, fibroids, Asherman syndrome and menopause.
He is currently Professor and Chair of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine.
Education & Training
Yale-New Haven Medical CenterFellowship, Reproductive Endocrinology and Infertility, 1993 - 1996- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1988 - 1992
Uconn School Of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2020 - 2028
CT State Medical License 1991 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Association of American Physicians 2024
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- KEEPS Cognitive and Affective Study Start of enrollment: 2007 May 01
- Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium Start of enrollment: 2023 Nov 01
Roles: Contact, Sponsor-Investigator, Principal Investigator
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain Start of enrollment: 2022 Oct 25
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Differential expression of microRNAs after induction of endometriosis in baboons.Ramanaiah Mamillapalli, Hanna Surmann, Niraj Joshi, Gregory Burns, Asgerally T Fazleabas
Biology of Reproduction. 2026-07-08 - Characterizing endometriosis and adenomyosis symptom clusters and their impact on quality of life in the All of Us Research Program.Oksana Goroshchuk, Noelia Pérez-Gómez, Francisco Carmona, Hugh S Taylor, Idhaliz Flores
Human Reproduction. 2026-07-01 - Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].Giorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, Marcello Ceccaroni, Robert L Coleman
Gynecologic Oncology. 2026-06-02
Journal Articles
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologySerdar E Bulun, Kristen A Matteson, Hugh S Taylor, American Journal of Obstetrics and Gynecology
- Progesterone Receptor Status Predicts Response to Progestin Therapy in EndometriosisValerie A Flores, Hugh S Taylor, The Journal of Clinical Endocrinology and Metabolism
Authored Content
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
Press Mentions
Precision Medicine May Be on the Way for Patients with EndometriosisMarch 20th, 2026- Endometriosis Often Takes Years to Diagnose. Startups Want to Change ThatJanuary 26th, 2026
- Is It Safe to Use Tylenol During Pregnancy?September 26th, 2025
Grant Support
- The Yale WRHR Career Development CenterYALE UNIVERSITY2004–2030
- Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy lossYALE UNIVERSITY2021–2026
- Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4YALE UNIVERSITY2019–2025
- Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4YALE UNIVERSITY2019–2025
- Project 1Eunice Kennedy Shriver National Institute Of Child Health &Human Development2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
